The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment
Abstract Oncotype DX (ODX) recurrence score (RS) is a validated tool to guide the use of adjuvant chemotherapy (AC) in hormone receptor+/HER2- breast cancer. In this analysis, we examine (1) characteristics associated with ODX testing and (2) the association between ODX RS and receipt of AC across a...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2022-03-01
|
| coleção: | npj Breast Cancer |
| Acesso em linha: | https://doi.org/10.1038/s41523-022-00394-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|